Abstract：
OBJECTIVE: To investigate the subjective effect of office-based blue laser therapy for inferior turbinate hypertrophy in patients with nasal obstruction.
METHODS: Patients with nasal obstruction who underwent office-based blue laser for the inferior turbinate hypertrophy between October 2022 and December 2023 were included in the study. The two outcome measures used to gauge the improvement in nasal obstruction and success of surgery were the Nasal Obstruction Symptom Evaluation (NOSE) scale and the Visual Analogue Scale (VAS). Patient\'s level of comfort during the procedure was also rated using a 10-point VAS scale.
RESULTS: A total of 14 patients were included in this study. The mean age of the study group was 41.47 ± 18.52 and the F/M ratio was 4.67. All patients reported significant improvement in nasal breathing. The mean NOSE score decreased significantly from 13.07 ± 3.89 pre-operatively to 2.64 ± 2.43 post-operatively (p = 0.002). Similarly, the mean VAS score decreased from 7.43 ± 0.85 to 2.0 ± 1.57 (p = 0.002) following surgery. The procedure was well-tolerated by all participants and the mean total score ranged from 6 to 9 with an average of 7.59 ± 1.34.
CONCLUSIONS: Office-based blue laser therapy for inferior turbinate hypertrophy may be an effective treatment modality for nasal obstruction from the patient\'s perspective. Although the procedures were tolerated well with no complications noted, these results should be cautiously interpreted until studies using objective measures are conducted.
METHODS: Patients with nasal obstruction who underwent office-based blue laser for the inferior turbinate hypertrophy between October 2022 and December 2023 were included in the study. The two outcome measures used to gauge the improvement in nasal obstruction and success of surgery were the Nasal Obstruction Symptom Evaluation (NOSE) scale and the Visual Analogue Scale (VAS). Patient\'s level of comfort during the procedure was also rated using a 10-point VAS scale.
RESULTS: A total of 14 patients were included in this study. The mean age of the study group was 41.47 ± 18.52 and the F/M ratio was 4.67. All patients reported significant improvement in nasal breathing. The mean NOSE score decreased significantly from 13.07 ± 3.89 pre-operatively to 2.64 ± 2.43 post-operatively (p = 0.002). Similarly, the mean VAS score decreased from 7.43 ± 0.85 to 2.0 ± 1.57 (p = 0.002) following surgery. The procedure was well-tolerated by all participants and the mean total score ranged from 6 to 9 with an average of 7.59 ± 1.34.
CONCLUSIONS: Office-based blue laser therapy for inferior turbinate hypertrophy may be an effective treatment modality for nasal obstruction from the patient\'s perspective. Although the procedures were tolerated well with no complications noted, these results should be cautiously interpreted until studies using objective measures are conducted.
摘要：
目的：探讨办公室蓝光激光治疗鼻塞患者下鼻甲肥大的主观效果。
方法：在2022年10月至2023年12月期间接受基于办公室的蓝色激光治疗下鼻甲肥大的鼻塞患者被纳入研究。用于评估鼻塞改善和手术成功的两个结果指标是鼻塞症状评估（NOSE）量表和视觉模拟量表（VAS）。患者在手术过程中的舒适度也使用10点VAS量表进行评估。
结果：本研究共纳入14例患者。研究组的平均年龄为41.47±18.52，F/M比为4.67。所有患者均报告鼻呼吸明显改善。平均NOSE评分从术前的13.07±3.89降至术后的2.64±2.43（p=0.002）。同样，术后平均VAS评分从7.43±0.85降至2.0±1.57(p=0.002).所有参与者均对该程序具有良好的耐受性，平均总分为6至9分，平均为7.59±1.34。
结论：从患者的角度来看，基于办公室的蓝色激光治疗下鼻甲肥大可能是一种有效的鼻塞治疗方式。虽然手术耐受良好，没有发现并发症，在使用客观指标进行研究之前,应谨慎解释这些结果.
方法：在2022年10月至2023年12月期间接受基于办公室的蓝色激光治疗下鼻甲肥大的鼻塞患者被纳入研究。用于评估鼻塞改善和手术成功的两个结果指标是鼻塞症状评估（NOSE）量表和视觉模拟量表（VAS）。患者在手术过程中的舒适度也使用10点VAS量表进行评估。
结果：本研究共纳入14例患者。研究组的平均年龄为41.47±18.52，F/M比为4.67。所有患者均报告鼻呼吸明显改善。平均NOSE评分从术前的13.07±3.89降至术后的2.64±2.43（p=0.002）。同样，术后平均VAS评分从7.43±0.85降至2.0±1.57(p=0.002).所有参与者均对该程序具有良好的耐受性，平均总分为6至9分，平均为7.59±1.34。
结论：从患者的角度来看，基于办公室的蓝色激光治疗下鼻甲肥大可能是一种有效的鼻塞治疗方式。虽然手术耐受良好，没有发现并发症，在使用客观指标进行研究之前,应谨慎解释这些结果.
